169 related articles for article (PubMed ID: 35103115)
1. Mesenchymal stem cell therapy for COVID-19.
Sengul F; Ozturk B; Vatansev H
Am J Stem Cells; 2021; 10(5):79-89. PubMed ID: 35103115
[TBL] [Abstract][Full Text] [Related]
2. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
3. May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm?
Sütlüoğlu H; Özdemir Ö
World J Transplant; 2021 Aug; 11(8):344-355. PubMed ID: 34447671
[TBL] [Abstract][Full Text] [Related]
4. Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19.
Klimczak A
World J Stem Cells; 2020 Sep; 12(9):1013-1022. PubMed ID: 33033561
[TBL] [Abstract][Full Text] [Related]
5. Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19.
Chouw A; Milanda T; Sartika CR; Kirana MN; Halim D; Faried A
Regen Eng Transl Med; 2022; 8(1):43-54. PubMed ID: 33723519
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
Lin F; Ichim TE; Pingle S; Jones LD; Kesari S; Ashili S
World J Stem Cells; 2020 Oct; 12(10):1067-1079. PubMed ID: 33178392
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19.
Hou XY; Danzeng LM; Wu YL; Ma QH; Yu Z; Li MY; Li LS
World J Stem Cells; 2024 Apr; 16(4):353-374. PubMed ID: 38690515
[TBL] [Abstract][Full Text] [Related]
8. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).
Lanzoni G; Linetsky E; Correa D; Alvarez RA; Marttos A; Hirani K; Cayetano SM; Castro JG; Paidas MJ; Efantis Potter J; Xu X; Glassberg M; Tan J; Patel AN; Goldstein B; Kenyon NS; Baidal D; Alejandro R; Vianna R; Ruiz P; Caplan AI; Ricordi C
CellR4 Repair Replace Regen Reprogram; 2020; 8():. PubMed ID: 34164564
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential.
Xiong J; Bao L; Qi H; Feng Z; Shi Y
Curr Stem Cell Res Ther; 2021; 16(2):105-108. PubMed ID: 32479246
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.
Abdelgawad M; Bakry NS; Farghali AA; Abdel-Latif A; Lotfy A
Stem Cell Res Ther; 2021 Aug; 12(1):469. PubMed ID: 34419143
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
[TBL] [Abstract][Full Text] [Related]
12. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
13. Virology of SARS-CoV-2 and management of nCOVID-19 utilizing immunomodulation properties of human mesenchymal stem cells-a literature review.
Sachdeva K; Kumar A; Mohanty S
Stem Cell Investig; 2021; 8():23. PubMed ID: 34917676
[TBL] [Abstract][Full Text] [Related]
14. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
Zayed M; Iohara K
Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review.
Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N
Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652
[TBL] [Abstract][Full Text] [Related]
17. The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19.
Gu J; Zhao Q; Han Z; Han Z
Curr Stem Cell Res Ther; 2021; 16(3):277-285. PubMed ID: 32729428
[TBL] [Abstract][Full Text] [Related]
18. The role of mesenchymal stem cells in COVID-19 treatment.
Yıldız Gülhan P
Tuberk Toraks; 2020 Dec; 68(4):430-436. PubMed ID: 33448740
[TBL] [Abstract][Full Text] [Related]
19. The Potential of Mesenchymal Stem Cells for the Treatment of Cytokine Storm due to COVID-19.
Li X; Yan M; Chen J; Luo Y
Biomed Res Int; 2021; 2021():3178796. PubMed ID: 34840969
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.
Arjmand B; Alavi-Moghadam S; Parhizkar Roudsari P; Rezaei-Tavirani M; Rahim F; Gilany K; Mohamadi-Jahani F; Adibi H; Larijani B
Front Cell Dev Biol; 2021; 9():675310. PubMed ID: 34195193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
